Literature DB >> 15307139

Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.

Astrid Koehler1, Frauke Bataille, Cornelia Schmid, Petra Ruemmele, Annette Waldeck, Hagen Blaszyk, Arndt Hartmann, Ferdinand Hofstaedter, Wolfgang Dietmaier.   

Abstract

Gene expression profiling of matched colorectal carcinomas and metastases could reveal key molecular events involved in tumour progression and metastasis. Expression profiles have been created from 25 colorectal carcinomas (CRCs, pT1-4), corresponding normal colonic mucosa, and 14 liver metastases using cDNA arrays containing 1176 cancer-related genes (Clontech). Hierarchical clustering clearly distinguished carcinomas from non-cancerous tissues, separated tumours into high-stage (pT4 and extensive lymph node or distant metastases) and low-stage (< or =pT3) groups, and correlated with the histopathological classification in 87% (33/38 cases). Most primary tumours and matched liver metastases clustered on terminal branches of the dendrogram. Statistical analysis (Mann-Whitney U-test) revealed 40 tumour-specific genes (29 up-regulated, 11 down-regulated) which allowed identification of malignant tissue samples by cluster analysis. A specific expression signature in matching metastases was not found, but a set of 23 classifier genes with statistically significant expression patterns in high- and low-stage tumours was identified. These genes may represent important targets in colorectal carcinogenesis and might provide useful clinicopathological tools in the management of colorectal cancer. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307139     DOI: 10.1002/path.1606

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  35 in total

1.  Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.

Authors:  Mehdi Manoochehri; Ashraf Karbasi; Mojgan Bandehpour; Bahram Kazemi
Journal:  Pathol Oncol Res       Date:  2013-10-14       Impact factor: 3.201

2.  Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.

Authors:  Marian Grade; Patrick Hörmann; Sandra Becker; Amanda B Hummon; Danny Wangsa; Sudhir Varma; Richard Simon; Torsten Liersch; Heinz Becker; Michael J Difilippantonio; B Michael Ghadimi; Thomas Ried
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer.

Authors:  Alfonso De Stefano; Chiara Carlomagno
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

5.  Polymorphisms in bone morphogenetic protein 3 and the risk of papillary thyroid cancer.

Authors:  Young Ock Kim; Il Ki Hong; Young Gyu Eun; Seong-Su Nah; Soojeong Lee; Su-Hak Heo; Hyung-Kee Kim; Ho-Yeon Song; Hak-Jae Kim
Journal:  Oncol Lett       Date:  2012-10-10       Impact factor: 2.967

Review 6.  Genomic markers for decision making: what is preventing us from using markers?

Authors:  Vicky M Coyle; Patrick G Johnston
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675

7.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

8.  Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence.

Authors:  Torsten Liersch; Marian Grade; Jochen Gaedcke; Sudhir Varma; Michael J Difilippantonio; Claus Langer; Clemens F Hess; Heinz Becker; Thomas Ried; B Michael Ghadimi
Journal:  Cancer Genet Cytogenet       Date:  2009-04-15

Review 9.  Clinical biomarkers in oncology: focus on colorectal cancer.

Authors:  Wendy De Roock; Bart Biesmans; Jef De Schutter; Sabine Tejpar
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Slow proliferation as a biological feature of colorectal cancer metastasis.

Authors:  A Anjomshoaa; S Nasri; B Humar; J L McCall; A Chatterjee; H-S Yoon; L McNoe; M A Black; A E Reeve
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.